Search Results - "Amat, Merce" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)

Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)

by Pennisi, Marzio, Russo, Giulia, Sgroi, Giuseppe, Bonaccorso, Angela, Parasiliti Palumbo, Giuseppe Alessandro, Fichera, Epifanio, Mitra, Dipendra Kumar, Walker, Kenneth B, Cardona, Pere-Joan, Amat, Merce, Viceconti, Marco, Pappalardo, Francesco
Published in BMC bioinformatics (10.12.2019)

Get full text

Journal Article

RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice

RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice

by Prabowo, Satria A, Painter, Hannah, Zelmer, Andrea, Smith, Steven G, Seifert, Karin, Amat, Merce, Cardona, Pere-Joan, Fletcher, Helen A
Published in Frontiers in immunology (30.04.2019)

Get full text

Journal Article

Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection

Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection

by Nell, Andre S, D'lom, Eva, Bouic, Patrick, Sabaté, Montserrat, Bosser, Ramon, Picas, Jordi, Amat, Mercè, Churchyard, Gavin, Cardona, Pere-Joan
Published in PloS one (26.02.2014)

Get full text

Journal Article

Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors

Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors

by Caturla, Francisco, Amat, Mercè, Reinoso, Raquel F., Calaf, Elena, Warrellow, Graham
Published in Bioorganic & medicinal chemistry letters (01.07.2006)

Get full text

Journal Article

Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx ® and Arcoxia

Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx ® and Arcoxia

by Caturla, Francisco, Amat, Mercè, Reinoso, Raquel F., Córdoba, Mónica, Warrellow, Graham
Published in Bioorganic & medicinal chemistry letters (15.06.2006)

Get full text

Journal Article

Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors

Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors

by Caturla, Francisco, Jiménez, Juan-Miguel, Godessart, Núria, Amat, Mercè, Cárdenas, Alvaro, Soca, Lídia, Beleta, Jordi, Ryder, Hamish, Crespo, María I
Published in Journal of medicinal chemistry (15.07.2004)

Get full text

Journal Article

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

by CARDONA IGLESIAS PERE JOAN, AMAT RIERA ISABEL, REYES BLANCA, SELGA ARIADNA, AMAT MERCE
Year of Publication 20.02.2014

Get full text

Patent

Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection: e89612

Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection: e89612

by Nell, Andre S, D'lom, Eva, Bouic, Patrick, Sabate, Montserrat, Bosser, Ramon, Picas, Jordi, Amat, Merce, Churchyard, Gavin, Cardona, Pere-Joan
Published in PloS one (01.02.2014)

Get full text

Journal Article

Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx super([registered]) and Arcoxia super([registered])

Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx super([registered]) and Arcoxia super([registered])

by Caturla, Francisco, Amat, Merce, Reinoso, Raquel F, Cordoba, Monica, Warrellow, Graham
Published in Bioorganic & medicinal chemistry letters (01.06.2006)

Get full text

Journal Article

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

by SELGA, ARIADNA, CARDONA IGLESIAS, PERE J, AMAT, MERCE, REYES, BLANCA, AMAT RIERA, ISABEL
Year of Publication 23.07.2019

Get full text

Patent

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

by AMAT RIERA ISABEL, REYES BLANCA, SELGA ARIADNA, AMAT MERCE
Year of Publication 30.07.2014

Get full text

Patent

Efficacy of RUTI® immunotherapy against active tuberculosis in a mouse model challenges the Koch phenomenon

Efficacy of RUTI® immunotherapy against active tuberculosis in a mouse model challenges the Koch phenomenon

by Soldevilla, Pablo, Buisan, Anna, Diaz, Jorge, Saladrigas, Sergi, Rosales, Yaiza, Arias, Lilibeth, Jimenez-Melsio, Alexandra, Vilaplana, Cristina, Amat Fabregat, Merce, Cardona, Pere-Joan
Published in Frontiers in Tuberculosis (08.11.2023)

Get full text

Journal Article

Formulación de lipomosas adecuada para tratar o prevenir la tuberculosis

Formulación de lipomosas adecuada para tratar o prevenir la tuberculosis

by REYES BLANCA, SELGA ARIADNA, CARDONA PERE JOAN, AMAT ISABEL, AMAT MERCE
Year of Publication 29.11.2013

Get full text

Patent

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

by AMAT, ISABEL, SELGA, ARIADNA, AMAT, MERCE, REYES, BLANCA, CARDONA, PERE JOAN
Year of Publication 27.12.2012

Get full text

Patent

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

by AMAT, ISABEL, SELGA, ARIADNA, AMAT, MERCE, REYES, BLANCA, CARDONA, PERE JOAN
Year of Publication 12.07.2012

Get full text

Patent

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS

by AMAT, ISABEL, SELGA, ARIADNA, AMAT, MERCE, REYES, BLANCA, CARDONA, PERE JOAN
Year of Publication 12.07.2012

Get full text

Patent

Liposome formulation suitable for treating or preventing tuberculosis

Liposome formulation suitable for treating or preventing tuberculosis

by AMAT, ISABEL, SELGA, ARIADNA, AMAT, MERCE, REYES, BLANCA, CARDONA, PERE JOAN
Year of Publication 04.07.2012

Get full text

Patent

Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study

Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study

by Amat, M, Barcons, M, Mancebo, J, Mateo, J, Oliver, A, Mayoral, J F, Fontcuberta, J, Vila, L
Published in Critical care medicine (01.01.2000)

Get more information

Journal Article

Liposome formulation suitable for treating or preventing tuberculosis

Liposome formulation suitable for treating or preventing tuberculosis

by REYES BLANCA, SELGA ARIADNA, CARDONA PERE JOAN, AMAT ISABEL, AMAT MERCE
Year of Publication 27.10.2017

Get full text

Patent

Racemic and Chiral Sulfoxides as Potential Prodrugs of the COX-2 Inhibitors Vioxx® and Arcoxia

Racemic and Chiral Sulfoxides as Potential Prodrugs of the COX-2 Inhibitors Vioxx® and Arcoxia

by Caturla, Francisco, Amat, Merce, Reinoso, Raquel F., Cordoba, Monica, Warrellow, Graham
Published in ChemInform (19.09.2006)

Get full text

Journal Article